fusion protein, polynucleotide, viral vector, pharmaceutical composition, use of a fusion protein, polynucleotide, viral vector or pharmaceutical composition, and method for treating or preventing viral hepatitis b infection or viral hepatitis c infection

摘要

The present application provides inter alia for a fusion protein comprising a polypeptide, wherein the polypeptide consists of an invariant chain fragment that is operably linked to an antigenic sequence, and wherein the invariant chain fragment consists of a portion of residues 17a. 97 of seq. Id: 1, wherein the portion comprises at least 5 contiguous residues of residues 77 to 92 of seq.